Cardiac Science Sets Date for Third Quarter, Nine-Month Results Release and Conference Call
More News related to CSCX
- Cardiac Science Corp. (CSCX) Announces Correction of Faulty AED Components
- Cardiac Science Notifies AED Customers of Nationwide Voluntary Medical Device Correction
- Cardiac Science and Cambridge Heart Announce Development Partnership
- Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing
- Cardiac Science (CSCX) Reports Large Q3 Loss; Issues Mixed Guidance for Q4
More News related to Press Releases
- Prudential Bancorp of Penn. (PBIP) Swings to Q4 Profit
- Pharmasset (VRUS) Reports Inline Q4 Loss of $0.53
- Sterling Banks (STBK) Swings to Q3 Loss
- Highlights From DE's Q4 Conference Call: Production Will Pick Up in 2010, But Overall Conditions to Remain Fairly Restrained
- Highlights From TIF's Q3 Conference Call: Sales Declines, But Less-Than-Expected; Raises FY Outlook
BOTHELL, Wash., Oct. 29 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, announced today that it will release its third quarter 2009 financial results on Monday, November 9, 2009 after market close. The Company has scheduled a conference call with analysts and investors for 4:30 p.m. Eastern Time. During the call, Cardiac Science management will discuss the financial results for the third quarter as well as the current business outlook.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)
To access the conference call, please dial 877.941.2332 and reference conference ID 4179087. Callers outside the U.S. can dial 480.629.9724. The call will also be webcast live at www.cardiacscience.com. An audio replay of the call will be available for 7 days following the call at 800.406.7325 for U.S. callers or 303.590.3030 for those calling from outside the U.S. The password required to access the replay is 4179087#. An archived webcast will also be available at www.cardiacscience.com for 90 days.
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, vital signs monitors, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.
For updates and information on worldwide defibrillation and cardiac monitoring, find us on the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB, and YouTube at http://budurl.com/CSonYT.
For more information,
Company Contact: Investor Contact: Media Contact:
---------------- ----------------- --------------
Mike Matysik Matt Clawson Christopher Gale
Cardiac Science Corporation Allen & Caron EVC Group Inc.
Senior Vice President and CFO 949.474.4300 646.201.5431
425.402.2009 matt@allencaron.com 203.570.4681
cgale@evcgroup.com
CSCX-F
SOURCE Cardiac Science Corporation
Related Categories
Press ReleasesStocks Mentioned
-0.08Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
